{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T18:40:44Z","timestamp":1762800044083,"version":"build-2065373602"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) is associated with generalized inflammation. The presence of CKD-related (non-traditional) cardiovascular disease (CVD) risk factors such as inflammation, oxidative stress and uraemic toxins worsen the CVD. A distinct form of lipoprotein alteration known as uraemic dyslipidaemia, characterized by normal low-density lipoprotein (LDL), reduced high density lipoprotein (HDL) and elevated triglyceride and lipoprotein (a) has been described in CKD. The combination of all these factors increase the cardiovascular risk in CKD patients. We evaluated the relationship of lipoprotein and inflammatory biomarkers to atherosclerotic vascular disease (AsVD) among stage 3 CKD, end stage kidney disease (ESKD) patients on continuous ambulatory peritoneal dialysis (CAPD) and haemodialysis (HD) and kidney transplant recipients (KTRs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional study of 40 adult (18\u201365 years) non-diabetic stage 3 CKD patients, 40 CAPD and 40 HD patients, 41 KTRs and 41 age- and sex-matched healthy controls. Socio-demographic and cardiovascular risk factors were documented and serum samples were analysed for inflammatory and lipoprotein markers. Echocardiography was performed and carotid intima media thickness (CIMT) was measured in all participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall prevalence of AsVD was 52.8% in the study population, with the highest burden of inflammation present in CAPD patients. Significantly increased levels of hsCRP, pentraxin-3, Lp(a) and Lp-PLA2 were seen in CAPD, compared to controls. Older age, male gender, reduced high-density lipoprotein (HDL-C) and elevated Lp(a) levels were independently associated with AsVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The burden of inflammation and lipoprotein abnormalities was greatest among end stage kidney disease (ESKD) patients and was the highest in CAPD patients. Lipoprotein(a) independently predicted AsVD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0323882","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T18:29:15Z","timestamp":1762799355000},"page":"e0323882","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dyslipidaemia and inflammation are risks for subclinical atherosclerotic vascular disease among chronic kidney failure patients in South Africa"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-6195","authenticated-orcid":true,"given":"S. O.","family":"Oguntola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.O.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dix-Peek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Snyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Olorunfemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vachiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Manga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7058-9725","authenticated-orcid":true,"given":"S.","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"pone.0323882.ref001","author":"US Renal Data System","year":"2023"},{"issue":"5","key":"pone.0323882.ref002","doi-asserted-by":"crossref","first-page":"719","DOI":"10.5301\/jn.5000047","article-title":"C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease","volume":"25","author":"D Jalal","year":"2012","journal-title":"J Nephrol"},{"key":"pone.0323882.ref003","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12882-015-0068-7","article-title":"Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease","volume":"16","author":"BT Lee","year":"2015","journal-title":"BMC Nephrol"},{"issue":"3","key":"pone.0323882.ref004","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ndt\/gfq471","article-title":"Inflammation, kidney function and albuminuria in the Framingham Offspring cohort","volume":"26","author":"A Upadhyay","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"pone.0323882.ref005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1152\/physrev.00016.2017","article-title":"PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer","volume":"98","author":"C Garlanda","year":"2018","journal-title":"Physiol Rev"},{"key":"pone.0323882.ref006","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fimmu.2019.00823","article-title":"Pentraxin 3 in Cardiovascular Disease","volume":"10","author":"G Ristagno","year":"2019","journal-title":"Front Immunol"},{"issue":"10","key":"pone.0323882.ref007","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3109\/0886022X.2011.618969","article-title":"Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients","volume":"33","author":"Y Xu","year":"2011","journal-title":"Ren Fail"},{"issue":"4","key":"pone.0323882.ref008","first-page":"315","article-title":"Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation","volume":"11","author":"CM Barbagallo","year":"2021","journal-title":"Life (Basel)"},{"issue":"14","key":"pone.0323882.ref009","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/elps.1150181424","article-title":"Biogenesis of lipoprotein(a) in human and animal hepatocytes","volume":"18","author":"EM Lobentanz","year":"1997","journal-title":"Electrophoresis"},{"issue":"10","key":"pone.0323882.ref010","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/ATVBAHA.117.309920","article-title":"Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort)","volume":"37","author":"A Bajaj","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"pone.0323882.ref011","first-page":"25","article-title":"Coronary artery disease in Asian Indians: lessons learnt and the role of lipoprotein(a)","volume":"49","author":"EA Enas","year":"1997","journal-title":"Indian Heart J"},{"issue":"3","key":"pone.0323882.ref012","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/01.ATV.16.3.471","article-title":"Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"16","author":"PJ Schreiner","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"pone.0323882.ref013","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/bbrc.1999.1066","article-title":"Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma","volume":"261","author":"K Asano","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"pone.0323882.ref014","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1074\/jbc.274.11.7018","article-title":"Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein","volume":"274","author":"DM Stafforini","year":"1999","journal-title":"J Biol Chem"},{"issue":"6","key":"pone.0323882.ref015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/scientificamerican0692-54","article-title":"Lipoprotein(a) in heart disease","volume":"266","author":"RM Lawn","year":"1992","journal-title":"Sci Am"},{"issue":"6","key":"pone.0323882.ref016","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI114625","article-title":"Lipoprotein (a). Heterogeneity and biological relevance","volume":"85","author":"AM Scanu","year":"1990","journal-title":"J Clin Invest"},{"issue":"17","key":"pone.0323882.ref017","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"RD Mosteller","year":"1987","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0323882.ref018","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"RM Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"pone.0323882.ref019","article-title":"Adiponectin and atherosclerosis risk factors in African Hemodialysis patients: A population at low risk for atherosclerotic cardiovascular disease","author":"CO Amira","journal-title":"Hemodialysis International"},{"issue":"5","key":"pone.0323882.ref020","first-page":"271","article-title":"High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis","volume":"38","author":"T Shoji","year":"1992","journal-title":"Clin Nephrol"},{"issue":"1","key":"pone.0323882.ref021","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12882-018-0986-2","article-title":"Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease","volume":"19","author":"KL Ma","year":"2018","journal-title":"BMC Nephrol"},{"issue":"18","key":"pone.0323882.ref022","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1074\/jbc.M114.611988","article-title":"Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin\/kexin type 9 through the low density lipoprotein receptor","volume":"290","author":"R Romagnuolo","year":"2015","journal-title":"J Biol Chem"},{"issue":"52","key":"pone.0323882.ref023","doi-asserted-by":"crossref","first-page":"40663","DOI":"10.1074\/jbc.C000761200","article-title":"Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages","volume":"275","author":"T Shimaoka","year":"2000","journal-title":"J Biol Chem"},{"key":"pone.0323882.ref024","doi-asserted-by":"crossref","first-page":"650989","DOI":"10.1155\/2013\/650989","article-title":"Lipoprotein(a) in cardiovascular diseases","volume":"2013","author":"M Malaguarnera","year":"2013","journal-title":"Biomed Res Int"},{"issue":"6","key":"pone.0323882.ref025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/cs0930519","article-title":"Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age","volume":"93","author":"D Lyons","year":"1997","journal-title":"Clin Sci (Lond)"},{"key":"pone.0323882.ref026","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/IJNRD.S160553","article-title":"Atherosclerotic vascular disease and its correlates in stable black South African kidney transplant recipients","volume":"11","author":"SO Oguntola","year":"2018","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"pone.0323882.ref027","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12882-019-1583-8","article-title":"Atherosclerotic vascular disease is more prevalent among black ESKD patients on maintenance CAPD in South Africa","volume":"20","author":"SO Oguntola","year":"2019","journal-title":"BMC Nephrol"},{"issue":"11","key":"pone.0323882.ref028","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2215\/CJN.02090212","article-title":"CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis","volume":"7","author":"JA Lamprea-Montealegre","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"pone.0323882.ref029","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1681\/ASN.2017070798","article-title":"HDL in CKD-The devil is in the detail","volume":"29","author":"F Kronenberg","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"pone.0323882.ref030","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1046\/j.1523-1755.1999.00788.x","article-title":"Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures","volume":"56","author":"HJ Milionis","year":"1999","journal-title":"Kidney Int"},{"issue":"10","key":"pone.0323882.ref031","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3109\/0886022X.2012.723580","article-title":"The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients","volume":"34","author":"K Turkmen","year":"2012","journal-title":"Ren Fail"},{"key":"pone.0323882.ref032","first-page":"28","article-title":"Markers of inflammation before and during peritoneal dialysis","volume":"27","author":"R Palomar-Fontanet","year":"2011","journal-title":"Adv Perit Dial"},{"issue":"2","key":"pone.0323882.ref033","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5414\/CN109037","article-title":"Initiation of peritoneal dialysis in the first weeks after catheter insertion: A comparison of a neutral-pH, low-GDP PD fluid and a conventional PD fluid","volume":"89","author":"K Farhat","year":"2018","journal-title":"Clin Nephrol"},{"issue":"6","key":"pone.0323882.ref034","first-page":"954","article-title":"Effect of high glucose-based peritoneal dialysis fluids on NLRP3-IL-1\u03b2 in human peritoneal mesothelial cells","volume":"49","author":"XY Li","year":"2017","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"pone.0323882.ref035","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3389\/fphys.2017.00762","article-title":"Proinflammatory effect of high glucose concentrations on HMrSV5 Cells via the Autocrine Effect of HMGB1","volume":"8","author":"Y Chu","year":"2017","journal-title":"Front Physiol"},{"key":"pone.0323882.ref036","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2369-11-25","article-title":"Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function","volume":"11","author":"DW Johnson","year":"2010","journal-title":"BMC Nephrol"},{"issue":"2","key":"pone.0323882.ref037","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/immu.200310022","article-title":"Biochemical and functional characterization of the interaction between pentraxin 3 and C1q","volume":"33","author":"AJ Nauta","year":"2003","journal-title":"Eur J Immunol"},{"issue":"3","key":"pone.0323882.ref038","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cdd.2008.173","article-title":"Endogenous PTX3 translocates at the membrane of late apoptotic human neutrophils and is involved in their engulfment by macrophages","volume":"16","author":"S Jaillon","year":"2009","journal-title":"Cell Death Differ"},{"issue":"1","key":"pone.0323882.ref039","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10047-012-0663-3","article-title":"Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients","volume":"16","author":"R Kanda","year":"2013","journal-title":"J Artif Organs"},{"issue":"11","key":"pone.0323882.ref040","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/ndt\/16.11.2240","article-title":"Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis","volume":"16","author":"SH Chung","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"pone.0323882.ref041","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5414\/CN108778","article-title":"Volume overload and its risk factors in South African chronic kidney disease patients: an appraisal of bioimpedance spectroscopy and inferior vena cava measurements","volume":"86","author":"MO Hassan","year":"2016","journal-title":"Clin Nephrol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0323882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T18:29:20Z","timestamp":1762799360000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0323882"}},"subtitle":[],"editor":[{"given":"Shukri","family":"AlSaif","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0323882","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]}}}